AUSTRALIAN-LISTED consumer food products company WattleHealth Australia (WHA) has secured a distribution agreement with Australian Pharmaceutical Industries (API) to deliver the manufacturer's infant formula throughout the country.
This is the first time the WattleHealth product will be made available to pharmacies including API's 3,000 affiliated Priceline Pharmacies, Pharmacist Advice and Soul Pattinson Chemists.
WHA said via an ASX announcement the distribution arrangement with API "provides the local market with a premium Australian made product through the pharmacy channel" increasing WattleHealth brand awareness within the domestic market and providing "significant opportunity for international expansion".
WHA executive chairman Lazarus Karasavvidis referred to the "highly respected pharmacy market" saying, "This will not only increase brand awareness and sales, but also the credibility of the brand which is important as we continue to grow our distribution footprint both domestically and internationally."
MEANWHILE, ASX-listed nutritional products business Eagle Health which signed a licensing agreement with Omni Innovation in Sep (PD 17 Sep) has announced it has commenced shipping its Australian developed and clinically proven diabetes pre-meal shake and opened four diabetes education and experience stores in Xiamen, the company's home city.
The above article was sent to subscribers in Pharmacy Daily's issue from 08 Dec 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Dec 17
